Background: To investigate the clinical efficacy of tonsillectomy on long-term clinical remission and renal survival of immunoglobulin A nephropathy (IgAN) patients in China. Methods: We performed a 130-month retrospective case-control study of 112 patients with idiopathic biopsy-diagnosed IgAN from 1983 to 1999. Fifty-four patients underwent tonsillectomy and 58 patients did not. The clinical remission rate during follow-up and variables to predict clinical remission were estimated by χ2 test and multivariate Cox regression analysis; renal survival was evaluated by Kaplan-Meier analysis. Results: Up to 2006, the follow-up period lasted 130 ± 50.3 months (60–276 months). The clinical remission rate was 46.3% in patients with tonsillectomy and 27.6% in those without tonsillectomy during follow-up. Multivariate analysis demonstrated that tonsillectomy was not an independent impact factor for renal clinical remission (p = 0.386). By Kaplan-Meier analysis, there was no significant difference in renal survival rate between patients with tonsillectomy and those without tonsillectomy (p = 0.059). Conclusion: The clinical remission rate in IgAN patients with tonsillectomy was higher than that in patients without tonsillectomy during follow-up. But within 130 months, it was difficult to find statistical difference in renal survival between IgAN patients with and without tonsillectomy.

Keywords:
Glomerulonephritis, IgA nephropathy, Tonsillectomy, Renal outcomes
1.
D’Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987;64:709–727.
2.
Li L, Liu Z: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 biopsies. Kidney Int 2004;66:920–923.
3.
Clarkson AR, Seymour AE, Thompson AJ, Haynes WD, Chan YL, Jackson B: IgA nephropathy: a syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol 1977;8:459–471.
4.
Yu Y, Li L, Wang Q, Liu Z, Zhang J, Wang T, Zhou W, Li N, Xue Y, Cheng R: Tonsillectomy therapy significantly impact on clinical remission in IgA nephropathy patients with gross hematuria. Chin Med J 1991;71:226–227.
5.
Xie Y, Nishi S, Ueno M, Imai N, Sakatsume M, Narita I, Suzuki Y, Akazawa K, Shimada H, Arakawa M, Gejyo F: The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int 2003;63:1861–1867.
6.
Tamura S, Masuda Y, Inokuchi I, Terasawa K, Sugiyama N: Effect of and indication for tonsillectomy in IgA nephropathy. Acta Otolaryngol 1993;508(suppl):23–28.
7.
Tomioka S, Miyoshi K, Tabata K, Hotta O, Taguma Y: Clinical study of chronic tonsillitis with IgA nephropathy treated by tonsillectomy. Acta Otolaryngol (Stockh) 1996;523(suppl):175–177.
8.
Tabata K, Matsutani S, Miyoshi K: IgA nephropathy treated by tonsillectomy: a clinical study of 100 patients. Stomato-Pharyngol 1995;7:151–155.
9.
Akagi H, Nishizaki K, Hattori K, Kosaka M, Fukushima K, Doi A, Masuda Y: Prognosis of tonsillectomy in patients with IgA nephropathy. Acta Otolaryngol 1999;540 (suppl):64–66.
10.
Hotta O, Taguma Y, Yoshizawa N, Oda T, Nishiyama J, Yusa N, Chiba S, Horigome I, Sudo K, Tomioka S: Long-term effects of intensive therapy combined with tonsillectomy in patients with IgA nephropathy. Acta Otolaryngol (Stockh) 1996;523(suppl):165–168.
11.
Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, Abe K, Taguma Y: Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 2001;38:736–743.
12.
Rasche FM, Schwarz A, Keller F: Tonsillectomy does not prevent a progressive course in IgA nephropathy. Clin Nephrol 1999;51:147–152.
13.
Akagi H, Kosaka M, Hattori K, Doi A, Fukushima K, Okano M, Kariya S, Nishizaki K, Sugiyama N, Shikata K, Makino H, Masuda Y: Long-term results of tonsillectomy as a treatment for IgA nephropathy. Acta Otolaryngol 2004;555(suppl):38–42.
14.
Nishi S, Xie Y, Ueno M, Imai N, Suzuki Y, Iguchi S, Fukase S, Mori H, Alchi B, Shimada H, Arakawa M, Gejyo F: A clinicopathological study on the long-term efficacy of tonsillectomy in patients with IgA nephropathy. Acta Otolaryngol 2004;555(suppl):49–53.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.